McDonald's Consumer Scare; Lilly Weight Loss Drug; Qualcomm Falls

On this episode of Stock Movers:- McDonald's (MCD) shares are lower after US sales fell 3.6% in the first quarter, mainly due to a decline in guest counts, marking the biggest drop in the chain's home market since 2020. The decline is attributed to a deterioration in consumer sentiment, making it harder for restaurants to lure in diners, with low-income customers being particularly affected.- Eli Lilly (LLY) dropped in the premarket after the drugmaker cut its adjusted earnings per share forecast for the full year. The company also reported first-quarter sales of its blockbuster weight-loss drug, Zepbound, that was in line with expectations. It also follows CVS' drug-benefits unit negotiated a deal to make Novo Nordisk A/S's Wegovy more widely available to its members, replacing Zepbound.- Qualcomm (QCOM) is falling after its revenue forecast for the period ending in June was $9.9 billion compared to $10.7 billion, which is slightly below analyst estimates. The company's outlook has renewed fears about the impact of tariffs on the smartphone market, which is Qualcomm's largest market. Shares fell over 5% in premarket trading following the announcement, despite the company's efforts to diversify its business beyond the phone market.- Nvidia (NVDA) shares jumped as Microsoft and Meta beats drove Mag 7 stocks higher. It comes with CEO Jensen Huang also saying he wants the Trump administration to change regulations for exporting AI technology to help American businesses capitalize on opportunities.See omnystudio.com/listener for privacy information.